Skip to main content

Advertisement

Table 5 Hemostatic parameters during ECCO2R therapy

From: Daily use of extracorporeal CO2 removal in a critical care unit: indications and results

Devices Duration of therapy (days) Platelets count (G/L) Anti-Xa activity (UI/mL) Hemolysis RBC transfusion during ECCO2R
J0 J1 J2 J3 J4 J5 J0 J1 J2 J3 J4 J5
All patients (n = 33) 7 [5–10] 202 [137–286] 167 [95–243] 143 [88–199] 130 [79–192] 128 [89–156] 124 [86–153] 0.22 [0.14–0.47] 0.26 [0.16–0.40] 0.33 [0.24–0.44] 0.33 [0.25–0.41] 0.30 [0.20–0.39] 0.35 [0.21–0.47] 16 (48) 16 (48)
Hemolung® (n = 17) 7 [5–10] 210 [163–264] 184 [108–243] 136 [88–208] 121 [79–174] 128 [89–153] 130 [88–151] 0.24 [0.15–0.50] 0.26 [0.20–0.36] 0.41 [0.30–0.53] 0.31 [0.25–0.42] 0.30 [0.20–0.38] 0.35 [0.30–0.49] 13 (76) 9 (53)
Prismalung® (n = 10) 5 [3–6] 153 [104–272] 126 [65–241] 124 [72–195] 105 [57–183] 82 [57–98] 77 [55–87] 0.13 [0.10–0.43] 0.17 [0.10–0.24] 0.25 [0.10–0.41] 0.37 [0.14–0.40] 0.23 [0.12–0.35] 0.20 [0.11–0.36] 1 (10) 4 (40)
ILA® (n = 4) 10 (5–19)* 226 [150–288] 181 [155–225] 172 [142–206] 186 [167–208] 151 [134–184] 173 [146–199] 0.19 [0.16–0.28] 0.36 [0.29–0.39] 0.26 [0.25–0.29] 0.37 [0.32–0.42] 0.31 [0.24–0.34] 0.26 [0.22–0.31] 1 (25) 3 (75)
Maquet® (n = 2) 6.5 (6–7)* 258 [205–311] 179 [163–195] 151 [141–162] 142 [130–153] 142 [130–153] 153 [153–153] 0.27 [0.25–0.30] 0.49 [0.44–0.53] 0.47 [0.46–0.47] 0.45 [0.42–0.47] 0.58 [0.55–0.61] 0.47 [0.46–0.47] 1 (50) 0 (0)
  1. Numbers are n (%) and median (interquartile range), except for * which corresponds to min and max. RBC red blood cells